Achenbach J. (2019). How an epic legal battle brought a secret drug database to light. The Washington Post. August 2, 2019. Retrieved 9/29/2019 from https://www.washingtonpost.com/health/how-an-epic-legal-battle-brought-a-secret-drug-database-to-light/2019/08/02/3bc594ce-b3d4-11e9-951e-de024209545d_story.html.
American Society of Addiction Medicine (ASAM). (2016). Opioid Addiction, 2016 Facts and Figures. Retrieved from http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf.
American Society of Addiction Medicine (ASAM). (2015). National Practice Guideline in the Use of Medications for the Treatment of Addiction Involving Opioid Use. Retrieved 4/8/2017 from https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf.
Associated Press (AP), Strickler L. (2019). Purdue Pharma, maker of painkiller OxyContin, files for bankruptcy as part of settlement. NBC News. September 15, 2019. Retrieved 9/21/2019 from https://www.nbcnews.com/news/us-news/purdue-pharma-maker-painkiller-oxycontin-files-bankruptcy-part-settlement-n1054711.
Associated Press (AP). (2018). Blue Cross of Alabama to Drop OxyContin Coverage in 2019. US News & World Report. November 7, 2018. Retrieved 10/4/2019 from https://www.usnews.com/news/healthiest-communities/articles/2018-11-07/blue-cross-of-alabama-to-drop-oxycontin-coverage-in-2019.
Boston Globe. (2012). Blue Cross Cuts Back on Pain Prescriptions. Retrieved September 29, 2019 from https://www.bostonglobe.com/metro/2014/04/07/state-largest-health-insurer-cuts-painkiller-prescriptions/UAgtbqJL0XPrsNASuJ27sJ/story.html.
Centers for Disease Control and Prevention (CDC, n.d.). Guideline for Prescribing Opioids for Chronic Pain. Fact Sheet. Retrieved 9/28/2019 from https://www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf.
Centers for Disease Control and Prevention (CDC) Public Health Law. (2015). Prescription Drug Time and Dosage Limit Laws. Published March 5, 2015. Retrieved 9/29/19 from https://www.cdc.gov/phlp/docs/menu_prescriptionlimits.pdf.
Centers for Disease Control and Prevention (CDC). (2019a). Understanding the Epidemic. Page last reviewed: December 19, 2018. Retrieved 9/29/2019 from https://www.cdc.gov/drugoverdose/epidemic/index.html.
Centers for Disease Control and Prevention (CDC). (2019b). Prescribing Practices: Changes in Opioid Prescribing Practices. Page last reviewed: August 13, 2019. Retrieved 9/29/2019 from https://www.cdc.gov/drugoverdose/data/prescribing/prescribing-practices.html.
Centers for Disease Control and Prevention (CDC). 2018. Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2018. Retrieved 9/21/2019 from https://www.cdc.gov/ drugoverdose/pdf/pubs/2018- cdc-drug-surveillance-report.pdf.
Chen L, Hedegaard H, Warner M. (2014). Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS data brief, no 166. Hyattsville, MD: National Center for Health Statistics. Retrieved September 4, 2017 from https://www.cdc.gov/nchs/products/databriefs/db166.htm.
Drug Enforcement Agency (DEA). (2019). National Prescription Drug Take Back Day, October 26, 2019. Retrieved October 10 2019 from https://www.deadiversion.usdoj.gov/drug_disposal/takeback/.
Demko P. (2019). Health plans don’t want patients on opioids. So what are they doing for pain? Politico. February 12, 2019. Retrieved 9/28/2019 from https://www.politico.com/story/2019/02/12/health-insurance-opioids-pain-1106969.
Dowell D, Haegerich T, Chou R. (2016). CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recommendations Rep 2016;65(No. RR-1):1–49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1.
Dunphy L, Winland-Brown J. (2016). Primary Care: The Art and Science of Advanced Practice Nursing, 5th ed. Philadelphia: F.A. Davis Company.
Britannica, Encyclopedia. (2017). Opium Wars. Retrieved August 28, 2017 from https://www.britannica.com/topic/Opium-Wars#ref632577.
Food and Drug Administration (FDA). (2019). News release. FDA approves first generic naloxone nasal spray to treat opioid overdose. Retrieved March 6, 2021 from https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-naloxone-nasal-spray-treat-opioid-overdose.
Food and Drug Administration (FDA). (2018). News release. FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults. Retrieved September 28, 2019 from https://www.fda.gov/news-events/press-announcements/fda-approves-first-non-opioid-treatment-management-opioid-withdrawal-symptoms-adults.
Greene J. (2018). Opioid laws hit physicians, patients in unintended ways. Modern Healthcare, July 30, 2018. Retrieved 9/28/2019 from https://www.modernhealthcare.com/article/20180730/NEWS/180739995/opioid-laws-hit-physicians-patients-in-unintended-ways.
Hedegaard, H., Miniño A.M., Warner M. (2018). Drug Overdose Deaths in the United States, 1999–2017. NCHS Data Brief, no 329. Hyattsville, MD: National Center for Health Statistics. 2018. Retrieved 9/29/2019 from https://www.cdc.gov/nchs/data/databriefs/db329-h.pdf.
Hedegaard H, Warner M, Miniño AM. (2017). Drug Overdose Deaths in the United States 1999–2016. NCHS Data Brief, No. 294. Hyattsville, MD: National Center for Health Statistics. Retrieved 4/14/2018 from https://www.cdc.gov/nchs/products/databriefs/db294.htm.
Joint Commission, The. (2018). Facts about Joint Commission Accreditation Standards for Health Care Organizations: Pain Assessment and Management. Retrieved 4/7/2018 from https://www.jointcommission.org/facts_about_joint_commission_accreditation_standards_for_health_care_organizations_pain_assessment_and_management/.
Katz J. (2017). Drug Deaths in America Are Rising Faster than Ever. The New York Times. January 5, 2017. Retrieved 4/14/2018 from https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html.
Klimas J, Gorfinkel L, Fairbairn N, et al. (2019). Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: A systematic review. JAMA Network Open 2(5):e193365. doi:10.1001/jamanetworkopen.2019.3365. Retrieved September 19, 2019 from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2732338.
Kreek M, Nielsen D, Butelman E, LaForge K. (2005). Genetic influences on impulsivity, risk taking, stress responsibility and vulnerability to drug abuse and addiction. Neurobiology of Addiction. Nature Neuroscience. Retrieved September 4, 2017 from https://www.researchgate.net/profile/David_Nielsen/publication/7514762_Genetic_Influences_on_Impulsivity_Risk_Taking_Stress_Responsivity_and_Vulnerability_to_Drug_Abuse_and_Addiction/links/09e41513114210281a000000/Genetic-Influences-on-Impulsivity-Risk-Taking-Stress-Responsivity-and-Vulnerability-to-Drug-Abuse-and-Addiction.pdf.
Mann B. (2019). Federal Judge Orders Release of Dataset Showing Drug Industry’s Role in Opioid Crisis. NPR Morning Edition. July 16, 2019. Retrieved 9/28/2019 from https://www.npr.org/sections/health-shots/2019/07/16/742430572/federal-judge-orders-release-of-dataset-showing-drug-industrys-role-in-opioid-cr.
McGreal C. (2019a). Drug makers conspired to worsen the opioid crisis. They have blood on their hands. The Guardian, August 29, 2019. Retrieved 9/29/2019 from https://www.theguardian.com/commentisfree/2019/aug/29/opioids-crisis-drug-makers-pharma.
McGreal, C. (2019b). Ex-pharma chief charged with flooding Appalachian towns with opioids. The Guardian. July 19, 2019. Retrieved 9/21/2019 from https://www.theguardian.com/us-news/2019/jul/19/opioids-crisis-appalachia-painkillers-drugs.
National Alliance for Model State Drug Laws (NAMSDL). (2017). Retrieved October 10, 2019 from http://www.namsdl.org.
National Council of State Boards of Nursing (NCSBN). (2014). What You Need to Know About Substance Use Disorder in Nursing. Retrieved 4/7/2018 from https://www.ncsbn.org/SUD_Brochure_2014.pdf.
National Council of State Boards of Nursing (NCSBN). (2011). Substance Use Disorder in Nursing: A Resource Manual and Guidelines for Alternative and Disciplinary Monitoring Programs. Retrieved 4/18/2018 from https://www.ncsbn.org/SUDN_11.pdf.
National Institute on Drug Abuse (NIDA). (2015.) Prescription Opioids and Heroin. Page updated January 2018. Retrieved 28 August 2017 from https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-abuse-heroin-use/introduction. Updated January 2018.
Rudd RA, Seth P, David F, Scholl L. (2016). Increases in drug and opioid- involved overdose deaths—United States, 2010–2015. MMWR Rep 65:1445–52. Retrieved from https://www.cdc.gov/mmwr/ volumes/65/wr/mm655051e1.htm.
Schuckit M. (2016). Treatment of Opioid Use Disorders. NEJM 375(4):357. Retrieved March 6, 2021 from http://www.nejm.org/doi/full/10.1056/NEJMra1604339#t=article.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Retrieved September 21, 2019, from https://www.samhsa.gov/data/report/2018-nsduh-annual-national-report.
Substance Abuse and Mental Health Services Administration (SAMHSA) and U.S Department of Health and Human Services Health Resources and Services Administration (HRSA). (2019). SBIRT: Screening, Brief Intervention, and Referral to Treatment. Retrieved 9/28/2019 from http://www.integration.samhsa.gov/clinical-practice/sbirt.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2018). Opioid Overdose Prevention Toolkit: Opioid Use Disorder Facts, Five Essential Steps for First Responders, Information for Prescribers, Safety Advice for Patients & Family Members, Recovering from Opioid Overdose. HHS Publication No. (SMA) 18-4742. First printed 2013. Revised 2014, 2016, 2018. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved 9/21/2019 from https://store.samhsa.gov/system/files/sma18-4742.pdf.
Substance Abuse and Mental Health Services Administration(SAMHSA). (2017). Screening, Brief Intervention, and Referral to Treatment (SBIRT). Last updated September 15, 2017. Retrieved September 21, 2019 from https://www.samhsa.gov/sbirt.
United Nations Office on Drug and Crime (UNODC). (2019). Executive Summary. World Drug Report 2019. United Nations publication, Sales No. E.19.XI.9.
U.S. Department of Justice, Drug Enforcement Administration (DEA). (2019). April 2019 17th National Drug Take Back Day Collection Results. Retrieved 9/28/2019 from https://takebackday.dea.gov/sites/default/files/NTBI%2017%20Totals-April2019.pdf.
U.S. Department of Health & Human Services (HHS). (2017). HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis. October 26, 2017. Retrieved 9/29/2019 from https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html.
Winter T, Schapiro R. (2019). Pennsylvania sues Oxycontin maker Purdue Pharma, says it targeted elderly and vets. NBC News. May 14, 2019. Retrieved 9/21/2019 from https://www.nbcnews.com/news/us-news/pennsylvania-sues-oxycontin-maker-purdue-pharma-says-it-targeted-elderly-n1005586.
World Health Organization (WHO). (2017). Access to buprenorphine, methadone and oral morphine. Retrieved August 28 , 2017 from http://www.who.int/hiv/amds/controlmedicine/en/.